Approval · Notice of Compliance 1797 · 1999
FENTANYL CITRATE: Notice of Compliance 1797
Issued July 6, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1797
- Date
- July 6, 1999
- Company
- Sabex Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic - adjunct to anaesthesia
- Canadian reference product
- FENTANYL CITRATE INJECTION (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FENTANYL CITRATE | 02240434 | Marketed |
Medicinal ingredients
- FENTANYL CITRATE 50 MCG per ML